Barriers to hepatitis C treatment in the era of direct acting antiviral agents

BACKGROUND: Direct-acting antivirals (DAA) are safe, effective treatment of hepatitis C virus (HCV). Suboptimal linkage to specialists and access to DAAs are the leading barriers to treatment; however, data are limited. AIM: Determine predictors of follow-up, receipt of DAAs, and reasons for the lac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aliment Pharmacol Ther
Main Authors: Lin, Michael, Kramer, Jennifer, White, Donna, Cao, Yumei, Tavakoli-Tabasi, Shahriar, Madu, Stella, Smith, Donna, Asch, Steven M., El-Serag, Hashem B., Kanwal, Fasiha
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5800315/
https://ncbi.nlm.nih.gov/pubmed/28949020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados